A retrospective cohort study using the TriNetX dataset revealed a significant correlation between GLP-1 RAs use and elevated aspiration pneumonia risk in patients undergoing gastrointestinal endoscopy, particularly among those receiving propofol sedation [20]
The key difference is the receptor model
[28] [29] Speaking to a Healthcare Professional Before Combining Treatments Consulting a GP, pharmacist, or specialist before combining retatrutide with any other substance is a patient safety imperative, covering medication interactions, nutritional assessment, contraception, and monitoring for serious adverse effects
They act on the same receptor pathway your natural GLP-1 uses, but they are designed to last much longer in the body
These drugs are also prescribed to diabetes patients with obesity and cardiovascular conditions
Linked with metabolic regulation and nutrient processing